Protagonist Therapeutics Overview
Protagonist Therapeutics Discounted Cash Flow
DCF Analysis for PTGX.
Get informed when a big investor buys or sells
+ FollowFair Value
$-4.07
Current Fair Value
$-4.07
↓ 103.6% Downside
Overvalued by 103.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison